| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-6,024.0660 | -6,086.8990 | -10,632.0280 | -13,425.2850 | -12,295.0700 |
|
Research and Development Expenses
|
-9,818.6470 | -9,428.7200 | -10,535.4460 | -17,616.6050 | -11,510.0740 |
| Depreciation, Amortization and Depletion
|
0 | 0 | -6.6930 | -15.0040 | -25.5750 |
|
Operating Income/Expenses
|
-15,842.7130 | -15,515.6190 | -21,174.1670 | -31,056.8940 | -23,830.7190 |
|
Total Operating Profit/Loss
|
-15,842.7130 | -15,515.6190 | -21,174.1670 | -31,056.8940 | -23,830.7190 |
| Total Net Finance Income/Expense
|
-739.9350 | -739.9350 | 0 | 215.1090 | 90.0980 |
|
Other Income/Expense, Non-Operating
|
84.0830 | 26.6010 | 63.0040 | -18.6760 | -- |
|
Non-Operating Income/Expenses, Total
|
-655.8520 | -713.3340 | 63.0040 | 196.4330 | 90.0980 |
|
Pretax Income
|
-16,498.5650 | -16,228.9530 | -21,111.1630 | -30,860.4610 | -23,740.6210 |
|
Net Income from Continuing Operations
|
-16,498.5650 | -16,228.9530 | -21,111.1630 | -30,860.4610 | -23,740.6210 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-16,498.5650 | -16,228.9530 | -21,111.1630 | -30,860.4610 | -23,740.6210 |
|
Net Income after Non-Controlling/Minority Interests
|
-16,498.5650 | -16,228.9530 | -21,111.1630 | -30,860.4610 | -23,740.6210 |
| Preferred/Other Stock Distribution
|
0 | 0 | -277.1190 | -- | -- |
|
Net Income Available to Common Stockholders
|
-16,498.5650 | -16,228.9530 | -21,388.2820 | -30,860.4610 | -23,740.6210 |
|
Diluted Net Income Available to Common Stockholders
|
-16,498.5650 | -16,228.9530 | -21,388.2820 | -30,860.4610 | -23,740.6210 |
| Basic EPS
|
-9.35 | -382.80 | -5.87k | -24.82k | -21.78k |
| Diluted EPS
|
-9.35 | -382.80 | -5.87k | -24.82k | -21.78k |
|
Basic Weighted Average Shares Outstanding
|
42.3970 | 42.3970 | 3.6430 | 1.2430 | 1.0900 |
|
Diluted Weighted Average Shares Outstanding
|
42.3970 | 42.3970 | 3.6430 | 1.2430 | 1.0900 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-16,498.5650 | -15,489.0180 | -21,111.1630 | -31,075.5700 | -23,830.7190 |
|
EBITDA
|
-16,498.5650 | -15,489.0180 | -21,104.4700 | -31,060.5660 | -23,805.1440 |
|
Normalized EBITDA
|
-16,683.6410 | -15,176.1830 | -17,801.4880 | -25,651.8380 | -19,073.2000 |
|
Normalized Income
|
-16,683.6410 | -15,916.1180 | -17,808.1810 | -25,451.7330 | -19,008.6770 |
|
Total Unusual Items
|
-185.0760 | 312.8350 | 3,302.9820 | 5,408.7280 | 4,731.9440 |
|
Total Unusual Items Excluding Goodwill
|
-185.0760 | 312.8350 | 3,302.9820 | 5,408.7280 | 4,731.9440 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 | 0 |
|
Tax Rate, Calculated
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
12/31/2022 - 3/29/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade